Wilson_1. LU Abstract for BSCGT_HUMAN GENE THERAPY 2017_word accepted.pdf (98.95 kB)
Quality approaches to allow multi-site equivalence in pluripotent stem cell based product manufacturing [Abstract]
conference contribution
posted on 2018-08-13, 13:48 authored by Maryam Shariatzadeh, Sammy WilsonSammy Wilson, Amit Chandra, Sujith Sebastian, Mark McCall, Rob ThomasRob Thomas, Nick Medcalf, Zoe Hewitt, David WilliamsQuality approaches to allow multi-site equivalence in pluripotent stem cell based product manufacturing [Abstract]
History
School
- Mechanical, Electrical and Manufacturing Engineering
Published in
Annual Conference of the British-Society-for-Gene-and-Cell-Therapy / Joint UK-Regenerative-Medicine-Platform Meeting HUMAN GENE THERAPYVolume
28Issue
8Pages
A21 - A21Citation
SHARIATZADEH, M. ... et al., 2017. Quality approaches to allow multi-site equivalence in pluripotent stem cell based product manufacturing. Human Gene Therapy, 28(8), pp. A21.Publisher
Mary Ann Liebert PublicationsVersion
- AM (Accepted Manuscript)
Publisher statement
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/Acceptance date
2017-04-19Publication date
2017Notes
This paper was presented at the annual conference of the British-Society-for-Gene-and-Cell-Therapy / Joint UK-Regenerative-Medicine-Platform Meeting, Royal Welsh Coll Mus & Drama, Cardiff, WALES, April 19–April 21. Final publication is available from Mary Ann Liebert, Inc., publishers https://doi.org/10.1089/hum.2017.29044.abstractsISSN
1043-0342eISSN
1557-7422Publisher version
Language
- en
